GSK3B and pancreatic neoplasm: Previous studies have shown that inhibition of GSK3β reduced the proliferation and survival of pancreatic cancer cells, which was associated with decreased cyclin D1 expression, Rb phosphorylation and secretion of matrix metalloproteinase-2 (MMP-2) [26, 29, 30].